Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
0.710 | GeneticVariation | BEFREE | Our study suggests lack of association between DNA polymorphisms rs2236479 of COL18A1 and rs2862296 of LOXL-4 with advanced POP in this population. | 29532123 | 2018 | |||||||
|
|
|
0.710 | GeneticVariation | GWASDB | Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis. | 22105264 | 2011 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Genome-wide association study of germline variants and breast cancer-specific mortality. | 30787463 | 2019 | |||||||
|
|
|
A | 0.700 | GeneticVariation | GWASCAT | Genomic atlas of the human plasma proteome. | 29875488 | 2018 | ||||||
|
|
|
A | 0.700 | GeneticVariation | GWASCAT | Genomic atlas of the human plasma proteome. | 29875488 | 2018 | ||||||
|
|
|
T | 0.700 | GeneticVariation | GWASCAT | Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. | 30275531 | 2018 | ||||||
|
|
|
GTGCC | 0.700 | CausalMutation | CLINVAR | Brain malformations associated with Knobloch syndrome--review of literature, expanding clinical spectrum, and identification of novel mutations. | 25456301 | 2014 | ||||||
|
|
|
0.700 | GeneticVariation | GWASDB | Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population. | 23555315 | 2013 | |||||||
|
|
|
0.700 | GeneticVariation | GWASDB | Including additional controls from public databases improves the power of a genome-wide association study. | 21849791 | 2011 | |||||||
|
|
|
0.700 | GeneticVariation | GWASDB | A pooling-based genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS). | 19961619 | 2009 | |||||||
|
|
|
T | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
T | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
T | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
T | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
A | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
C | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
C | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
GC | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
G | 0.700 | GeneticVariation | CLINVAR | |||||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
GC | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
0.100 | GeneticVariation | BEFREE | Our results suggest that the RFC-1 80G>A (rs1051266) SNP exerts a potentially protective effect against the risk of adverse drug reactions in Chinese RA patients treated with MTX. | 31099054 | 2019 |